Skip to main content
Toggle navigation
Login
Search
Home
Back
Favorite
0
Like
Facebook
Tweet
Print
Session I: Lymphoma
Debate: Patients With Early Progressing Follicular Lymphoma Generally Should Receive CAR-T Therapy Vs Other Newer Agents After Two Lines Of Therapy - CAR-T
Wednesday, July 20, 2022
9:25 AM – 9:40 AM
Debate Speaker(s)
Sarah Rutherford, MD
Assistant Professor of Medicine
Weill Cornell Medicine
New York, New York